Pfizer Joined in a Depo-Provera Meningioma Case in California State Court
Research and legal claims highlight alleged mutagenic risks of Depo-Provera, linking long-term use to increased meningioma frequency and recurrence LOS ANGELES, CA, UNITED STATES, November 17, 2025 /EINPresswire.com/ -- “To this day, Pfizer does …